文献速递肝病

TM6SF2 E167K变异携带者非酒精性脂肪性肝病中多不饱和脂肪酸的肝脏脂质合成受损

Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD.
PubMed 文献 · J Hepatol · 2017-02-22

研究比较TM6SF2 E167K变异携带者(EK/KK)与野生型(EE)非酒精性脂肪性肝病患者的肝脏和血清脂质组、基因表达及体外肝细胞脂质处理,发现变异携带者肝脏甘油三酯和胆固醇酯升高、磷脂酰胆碱降低,多不饱和脂肪酸向甘油三酯和磷脂酰胆碱的掺入减少,提示多不饱和脂肪酸来源的肝脏脂质合成受损。

要点

  • TM6SF2EK/KK组肝脏甘油三酯和胆固醇酯高于TM6SF2EE组,肝脏磷脂酰胆碱低于TM6SF2EE组。
  • 两组肝脏和血清甘油三酯及肝脏磷脂酰胆碱中多不饱和脂肪酸缺乏,但肝脏游离脂肪酸中多不饱和脂肪酸相对富集。
  • 体外TM6SF2敲低肝细胞中多不饱和脂肪酸向甘油三酯和磷脂酰胆碱的掺入减少。

核心结论

  • 多不饱和脂肪酸来源的肝脏脂质合成受损,可能参与TM6SF2 E167K变异携带者磷脂酰胆碱缺乏和肝内甘油三酯增加。

研究设计与样本

  • 研究纳入接受肝活检并明确TM6SF2基因型、血清和肝脏脂质组、基因表达及组织学特征的对象,并在HuH-7细胞中进行TM6SF2敲低后比较不同脂肪酸向甘油三酯、胆固醇酯和磷脂酰胆碱的掺入。

主要发现

  • TM6SF2EK/KK组与TM6SF2EE组年龄、性别、BMI和HOMA-IR相似。
  • TM6SF2EK/KK组肝脏甘油三酯和胆固醇酯高于TM6SF2EE组,肝脏磷脂酰胆碱低于TM6SF2EE组(p<0.05)。
  • 肝脏和血清甘油三酯及肝脏磷脂酰胆碱中多不饱和脂肪酸缺乏,而肝脏游离脂肪酸中多不饱和脂肪酸相对富集(p<0.05)。
  • TM6SF2敲低肝细胞中多不饱和脂肪酸向甘油三酯和磷脂酰胆碱的掺入减少(p<0.05)。
  • 变异携带者肝脏TM6SF2表达降低,并与受多不饱和脂肪酸调控的基因共表达。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Carriers of the transmembrane 6 superfamily member 2 E167K gene variant (TM6SF2EK/KK) have decreased expression of the TM6SF2 gene and increased risk of NAFLD and NASH. Unlike common 'obese/metabolic' NAFLD, these subjects lack hypertriglyceridemia and have lower risk of cardiovascular disease. In animals, phosphatidylcholine (PC) deficiency results in a similar phenotype. PCs surround the core of VLDL consisting of triglycerides (TGs) and cholesteryl-esters (CEs). We determined the effect of the TM6SF2 E167K on these lipids in the human liver and serum and on hepatic gene expression and studied the effect of TM6SF2 knockdown on hepatocyte handling of these lipids. METHODS: Liver biopsies were taken from subjects characterized with respect to the TM6SF2 genotype, serum and liver lipidome, gene expression and histology. In vitro, after TM6SF2 knockdown in HuH-7 cells, we compared incorporation of different fatty acids into TGs, CEs, and PCs. RESULTS: The TM6SF2EK/KK and TM6SF2EE groups had similar age, gender, BMI and HOMA-IR. Liver TGs and CEs were higher and liver PCs lower in the TM6SF2EK/KK than the TM6SF2EE group (p<0.05). Polyunsaturated fatty acids (PUFA) were deficient in liver and serum TGs and liver PCs but hepatic free fatty acids were relatively enriched in PUFA (p<0.05). Incorporation of PUFA into TGs and PCs in TM6SF2 knockdown hepatocytes was decreased (p<0.05). Hepatic expression of TM6SF2 was decreased in variant carriers, and was co-expressed with genes regulated by PUFAs. CONCLUSIONS: Hepatic lipid synthesis from PUFAs is impaired and could contribute to deficiency in PCs and increased intrahepatic TG in TM6SF2 E167K variant carriers.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Luukkonen PK, Zhou Y, Nidhina Haridas PA, et al. Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD. J Hepatol. 2017. PMID: 28235613. doi:10.1016/j.jhep.2017.02.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。